High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinomaCarla Hebert, John J. Sauk, Kathleen Norris et al.|Molecular Cancer|2007Cited by 275
PPARγ‐mediated antineoplastic effect of NSAID sulindac on human oral squamous carcinoma cellsNikolaos G. Nikitakis, John J. Sauk, Carla Hebert et al.|International Journal of Cancer|2002Cited by 45
Water-soluble polymers for targeted drug delivery to human squamous carcinoma of head and neckAnjan Nan, John J. Sauk, Hamidreza Ghandehari et al.|Journal of drug targeting|2005Cited by 44
Hypoxia-inducible factor-1α polymorphisms and TSC1/2 mutations are complementary in head and neck cancersCarla Hebert, John J. Sauk, Pallavi Parashar et al.|Molecular Cancer|2006Cited by 37
Endostatin inhibits nitric oxide and diminishes <i>VEGF</i> and <i>collagen XVIII</i> in squamous carcinoma cellsCarla Hebert, John J. Sauk, Hessam Siavash et al.|International Journal of Cancer|2004Cited by 10